Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Diffuse Intrinsic Pontine Glioma × Gemcitabine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 5 Pancreatic Adenocarcinoma 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, B-Cell 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

lorlatinib 1 larotrectinib 1 fimepinostat 1 Temozolomide 1 Irinotecan 1 Gemcitabine 1 CUDC-907 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02992015 2025-03-07

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

University of Colorado, Denver

Phase EARLY_PHASE1 Completed

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡